CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTH CARE RESOURCE UTILIZATION IN UNRESECTABLE, LOCALLY ADVANCED, STAGE III NON-SMALL CELL LUNG CANCER: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANADA

被引：1
|
作者：
Kurosky, S. [1 ]
Klein, A. B. [2 ]
Parikh, R. C. [1 ]
Trantham, L. [1 ]
Zhang, Y. [2 ]
Levine, C. A. [1 ]
Kaye, J. A. [3 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] RTI Hlth Solut, Waltham, MA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.286
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN239
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [41] Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States
    Haque, Waqar
    Verma, Vivek
    Butler, E. Brian
    Teh, Bin S.
    ANTICANCER RESEARCH, 2019, 39 (06) : 3137 - 3140
  • [42] Real-World Biomarker Testing and Treatment Patterns for Locally Advanced and Metastatic Non-Small Cell Lung Cancer in Canada
    Laforty, C.
    Tong, M.
    Sharma, A.
    Kim, Y.
    Devost, N.
    Qadeer, R.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S656 - S657
  • [43] A LONGITUDINAL REVIEW OF TREATMENT PATTERNS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) FROM COMMUNITY PRACTICE IN THE UNITED STATES
    Chaugule, S.
    Sullivan, S. D.
    Ramsey, S.
    Kreilick, C.
    Foltz-Boklage, S.
    Haslip, S.
    Gilmore, J.
    Sarma, S.
    Asche, C.
    Seal, B.
    VALUE IN HEALTH, 2012, 15 (04) : A210 - A210
  • [44] Efficacy and toxicity of concomitant chemoradiotherapy with docetaxel and cisplatin in unresectable locally advanced stage non-small cell lung cancer
    Kaya, A. O.
    Buyukberber, S.
    Coskun, U.
    Yildiz, R.
    Yaman, E.
    Ozturk, B.
    Kalender, M. E.
    Orhan, O.
    Sevinc, A.
    Benekli, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 140 - 140
  • [45] Smooth sailing for immunotherapy for unresectable stage III non-small cell lung cancer: the PACIFIC study
    Khandekar, Melin J.
    Jain, Rakesh
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S16 - S20
  • [46] Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials
    Bortolot, Martina
    Cortiula, Francesco
    Fasola, Gianpiero
    De Ruysscher, Dirk
    Naidoo, Jarushka
    Hendriks, Lizza E. L.
    CANCER TREATMENT REVIEWS, 2024, 129
  • [47] Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study
    Moore, Amanda M.
    Nooruddin, Zohra
    Reveles, Kelly R.
    Datta, Paromita
    Whitehead, Jennifer M.
    Franklin, Kathleen
    Alkadimi, Munaf
    Williams, Madison H.
    Williams, Ryan A.
    Smith, Sarah
    Reichelderfer, Renee
    Cotarla, Ion
    Brannman, Lance
    Frankart, Andrew
    Mulrooney, Tiernan
    Hsieh, Kristin
    Simmons, Daniel J.
    Jones, Xavier
    Frei, Christopher R.
    CURRENT ONCOLOGY, 2023, 30 (09) : 8411 - 8423
  • [48] Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancer
    Ahn, Myung-Ju
    JOURNAL OF THORACIC DISEASE, 2018, 10 (03) : 1205 - 1206
  • [49] Radiation Resource Utilization and Cost of Care of the Patient with Stage IV Non-Small Cell Lung Cancer
    Berman, A. T.
    Crimins, N.
    Gabriel, P. E.
    Aakhus, E.
    Braun, J.
    Shulman, L.
    Evans, T. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E390 - E390
  • [50] Changing Patterns of Care for Locally Advanced Non-Small Cell Lung Cancer: Implications for Quality Initiatives
    Christodouleas, J. P.
    Hall, M. D.
    van der Pas, M.
    Upasani, S.
    Guo, W.
    Schultheiss, T. E.
    Goldwein, J. W.
    Gabriel, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S120 - S120
12345